Organization Overview
Historical Acquisition Tree
Alternative names
Key: Leo Pharma (5) Acquired (11)
avacincaptad pegol (Izervay) (2023 NDA)
azelaic acid (azelex) (2002)
betamethasone (celestone) (2006)
calcipotriene (dovonex) (1993 NDA)
enfortumab vedotin (Padcev) (2019)
enzalutamide (xtandi) (2020)
fezolinetant (Veozah) (2023 NDA)
gilteritinib (2018)
ingenol mebutate (picato) (2012 NDA)
mirabegron (myrbetriq) (2021)
pinacidil (Pindac) (1989)
prednisone (meticorten) (2006)
solifenacin (vesicare) (2020)
tacrolimus (prograf) (2000)
tinzaparin (Innohep) (2000)
tralokinumab (Adtralza) (2021 NDA)
Key: Leo Pharma (13) Acquired (81)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (3 trials)
abiraterone (zytiga) (5 trials)
acetaminophen (tylenol) (1 trial)
acetylsalicylic acid (aspirin) (4 trials)
acitretin (soriatane) (1 trial)
alefacept (Amevive) (18 trials)
alemtuzumab (campath) (3 trials)
amphotericin b (fungizone) (7 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (5 trials)
atorvastatin (lipitor) (4 trials)
azathioprine (imuran) (2 trials)
basiliximab (Simulect) (9 trials)
betamethasone (celestone) (40 trials)
bicalutamide (casodex) (4 trials)
Bismuth Subcitrate Potassium (Pylera) (1 trial)
calcipotriene (dovonex) (46 trials)
capsaicin (qutenza) (6 trials)
conivaptan (vaprisol) (5 trials)
cyclosporine (sandimmune) (9 trials)
diclofenac (voltaren) (1 trial)
dipyridamole (persantine) (1 trial)
dobutamine (dobutrex) (1 trial)
enzalutamide (xtandi) (81 trials)
epoprostenol (veletri) (1 trial)
everolimus (zortress) (5 trials)
fidaxomicin (dificid) (7 trials)
finasteride (Proscar) (1 trial)
fluconazole (diflucan) (4 trials)
flutamide (eulexin) (3 trials)
fluticasone (cutivate) (2 trials)
fusidic acid (Fucidin) (2 trials)
gabapentin (neurontin) (7 trials)
glimepiride (amaryl) (2 trials)
guselkumab (tremfya) (1 trial)
ingenol mebutate (picato) (65 trials)
interferon alpha-2b (Intron-A) (1 trial)
ipragliflozin (sublet) (47 trials)
leuprolide (lupron) (12 trials)
levofloxacin (levaquin) (1 trial)
lidocaine (xylocaine) (1 trial)
methylprednisolone (medrol) (12 trials)
micafungin (mycamine) (32 trials)
minocycline (minocin) (6 trials)
mirabegron (myrbetriq) (66 trials)
motexafin gadolinium (2 trials)
mycophenolate (CellCept) (40 trials)
nicardipine (cardene) (1 trial)
oxybutynin (ditropan) (3 trials)
oxycodone (oxycontin) (1 trial)
palonosetron (aloxi) (1 trial)
pantoprazole (protonix) (1 trial)
pimecrolimus (elidel) (5 trials)
posaconazole (noxafil) (1 trial)
prednisone (meticorten) (34 trials)
quinapril (accupril) (1 trial)
regadenoson (lexiscan) (34 trials)
ribavirin (virazole) (1 trial)
risperidone (risperdal) (2 trials)
rituximab (rituxan) (5 trials)
rivaroxaban (xarelto) (1 trial)
sirolimus (rapamune) (7 trials)
solifenacin (vesicare) (67 trials)
tacrolimus (prograf) (156 trials)
tamsulosin (flomax) (25 trials)
tinzaparin (Innohep) (18 trials)
tocilizumab (actemra) (2 trials)
tolterodine (detrol) (9 trials)
triamcinolone (kenalog) (1 trial)
vancomycin (Vancocin) (4 trials)
Key: Leo Pharma (10) Acquired (98)
adenosine (Adenocard) (6 trials)
aflibercept (zaltrap) (5 trials)
alitretinoin (panretin) (1 trial)
allopurinol (zyloprim) (1 trial)
avacincaptad pegol (Izervay) (8 trials)
azacitidine (vidaza) (3 trials)
bevacizumab (avastin) (8 trials)
capecitabine (xeloda) (3 trials)
carboplatin (paraplatin) (7 trials)
celecoxib (celebrex) (2 trials)
certolizumab pegol (cimzia) (4 trials)
cisplatin (platinol) (8 trials)
cyclophosphamide (cytoxan) (2 trials)
cytarabine (cytosar-u) (8 trials)
darbepoetin alfa (aranesp) (4 trials)
daunorubicin (cerubidine) (2 trials)
degarelix acetate (firmagon) (2 trials)
deoxycholic acid (kybella) (1 trial)
docetaxel (taxotere) (14 trials)
enfortumab vedotin (Padcev) (19 trials)
enoxaparin (lovenox) (4 trials)
erlotinib (tarceva) (65 trials)
etoposide (vepesid) (2 trials)
fezolinetant (Veozah) (15 trials)
fludarabine (fludara) (4 trials)
fluorouracil (efudex) (6 trials)
gemcitabine (gemzar) (12 trials)
goserelin (zoladex) (3 trials)
idarubicin (idamycin) (3 trials)
immune globulin (human) (Gamastan) (2 trials)
inactivated influenza vaccine (5 trials)
insulin human (humulin) (1 trial)
interferon alfacon-1 (Infergen) (1 trial)
isavuconazonium (cresemba) (32 trials)
isotretinoin (Accutane) (2 trials)
itraconazole (sporanox) (5 trials)
leflunomide (arava) (2 trials)
linaclotide (linzess) (6 trials)
midostaurin (rydapt) (2 trials)
mitoxantrone (novantrone) (3 trials)
nateglinide (starlix) (2 trials)
nitrazepam (Mogadon) (1 trial)
ondansetron (zofran) (1 trial)
oxaliplatin (eloxatin) (7 trials)
paclitaxel (taxol) (13 trials)
peficitinib (Vonjo) (31 trials)
penicillamine (cuprimine) (1 trial)
pentamidine (pentam) (4 trials)
pioglitazone (actos) (3 trials)
porcine lung surfactant (1 trial)
quetiapine (seroquel) (11 trials)
radiolabeled albumin technetium Tc-99m albumin colloid kit (Microlite) (1 trial)
radium-223 (xofigo) (2 trials)
ranibizumab (lucentis) (8 trials)
sargramostim (leukine) (3 trials)
sevelamer (renagel) (2 trials)
sitagliptin (januvia) (13 trials)
sulindac (clinoril) (6 trials)
talazoparib (talzenna) (2 trials)
tralokinumab (Adtralza) (13 trials)
ustekinumab (stelara) (1 trial)
Key: Leo Pharma (16) Acquired (111)
alteplase (Activase) (1 trial)
anastrozole (arimidex) (2 trials)
antithrombin iii (human) (thrombate iii) (1 trial)
atezolizumab (Tecentriq) (2 trials)
atrial natriuretic peptide (1 trial)
autologous skeletal myoblast (1 trial)
Bivalent group A and C meningococcal vaccine (Menomune-A/C) (1 trial)
bortezomib (velcade) (2 trials)
brexpiprazole (rexulti) (1 trial)
cetuximab (erbitux) (2 trials)
cinacalcet (sensipar) (1 trial)
cromoglicic acid (Intal) (2 trials)
deferasirox (exjade) (1 trial)
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix) (1 trial)
dupilumab (dupixent) (1 trial)
dutasteride (avodart) (1 trial)
epirubicin (ellence) (1 trial)
exemestane (aromasin) (3 trials)
Filgrastim (neupogen) (3 trials)
ganciclovir (cytovene) (1 trial)
glyco-conjugate neisseria meningitidis serogroup c vaccine (1 trial)
human embryonic stem cell derived retinal pigmented epithelial cells (1 trial)
hydrocortisone (solu-cortef) (2 trials)
irinotecan (Camptosar) (2 trials)
Isatuximab (Sarclisa) (1 trial)
linagliptin (tradjenta) (1 trial)
malononitrilamide-715 (4 trials)
methyl aminolevulinate (metvixia) (1 trial)
mifepristone (mifeprex) (1 trial)
mometasone (elocon) (2 trials)
mupirocin (bactroban) (2 trials)
naproxen (naprosyn) (3 trials)
paliperidone (invega) (1 trial)
panitumumab (vectibix) (1 trial)
pazopanib (votrient) (1 trial)
pemetrexed (alimta) (2 trials)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (2 trials)
sorafenib (nexavar) (4 trials)
sulfamethoxazole (gantanol) (1 trial)
technetium tc-99m sestamibi (Cardiolite) (2 trials)
technetium tc-99m tetrofosmin kit (Myoview) (1 trial)
tivozanib (Fotivda) (2 trials)
topotecan (hycamtin) (1 trial)
trastuzumab (herceptin) (1 trial)
valaciclovir (Valtrex) (3 trials)
valganciclovir (Valcyte) (1 trial)
venetoclax (venclexta) (2 trials)
Volrubigene ralaparvovec (1 trial)
Key: Leo Pharma (14) Acquired (94)
asparaginase (elspar) (1 trial)
bupropion (wellbutrin) (1 trial)
cabazitaxel (jevtana kit) (1 trial)
cemiplimab (libtayo) (1 trial)
cladribine (leustatin) (1 trial)
clopidogrel (plavix) (1 trial)
crizotinib (xalkori) (1 trial)
desipramine (pertofrane) (1 trial)
esomeprazole (nexium) (1 trial)
ethinyl estradiol (Estinyl) (1 trial)
fluocinolone acetonide (synalar) (1 trial)
gemfibrozil (lopid) (2 trials)
ivosidenib (tibsovo) (1 trial)
methadone (methadose) (1 trial)
metoprolol (lopressor) (2 trials)
mitiglinide (Glufast) (1 trial)
moxifloxacin (avelox) (5 trials)
omeprazole (prilosec) (3 trials)
petrolatum, white (Vaseline) (3 trials)
pilocarpine (ocusert) (2 trials)
propranolol (inderal) (1 trial)
repaglinide (prandin) (2 trials)
rimabotulinumtoxinB (Myobloc) (1 trial)
rosuvastatin (crestor) (3 trials)
Key: Leo Pharma (1) Acquired (13)
Acne Vulgaris (Phase 2)
Acute Chest Syndrome (Phase 3)
Acute Lung Injury (Phase 3)
Alopecia (Phase 2)
Alopecia Areata (Phase 2)
Atrophy (Phase 1)
Birth Weight (Phase 4)
Body Weight (Phase 4)
Carcinoma (Phase 3)
Carcinoma, Basal Cell (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Condylomata Acuminata (Phase 2)
Connective Tissue Diseases (Phase 2)
Dermatitis (Phase 4)
Dermatitis, Atopic (Phase 4)
Dermatitis, Contact (Phase 4)
Dermatitis, Occupational (Phase 4)
Dermatitis, Phototoxic (Phase 1)
Disseminated Intravascular Coagulation (Phase 2)
Eczema (Phase 4)
Embolism (Phase 4)
Fetal Growth Retardation (Phase 4)
Hyperparathyroidism (Phase 1)
Hyperparathyroidism, Secondary (Phase 1)
Impetigo (Phase 4)
Inflammation (Phase 4)
Insulin Resistance (Phase 4)
Keratosis (Phase 4)
Keratosis, Actinic (Phase 4)
Kidney Failure, Chronic (Phase 4)
Liver Neoplasms (Phase 3)
Lung Injury (Phase 3)
Lupus Erythematosus, Discoid (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Lymphoma (Phase 2)
Mastocytosis (Phase 2)
Molluscum Contagiosum (Phase 1)
Multiple Myeloma (Phase 2)
Neoplasm Metastasis (Phase 1)
Neoplasms, Plasma Cell (Phase 2)
Prurigo (Phase 2)
Pruritus (Phase 2)
Psoriasis (Phase 4)
Pulmonary Embolism (Phase 4)
Renal Insufficiency (Phase 4)
Respiratory Distress Syndrome (Phase 3)
Respiratory Distress Syndrome, Newborn (Phase 3)
Sepsis (Phase 2)
Syndrome (Phase 3)
Thromboembolism (Phase 4)
Thrombosis (Phase 4)
Venous Thromboembolism (Phase 4)
Venous Thrombosis (Phase 4)
Warts (Phase 2)